Reineke Schoot, Pediatric oncologist and Groupleader Drug Development for Solid Tumors at Princess Máxima Center for pediatric oncology, shared a post on LinkedIn:
“Thrilled to be featured in Nature Cancer ‘the 2025 generation’, highlighting the opportunities and challenges of 12 new groupleaders developing their independent research groups.
Grateful for the opportunities I’ve been given in the Princess Máxima Center for Pediatric Oncology and the mentorship and support of my colleagues. Looking hopeful toward the future and ready to commit with full dedication to drug development for children with soft tissue sarcoma!”
More posts featuring Reineke Schoot.